JLL Releases 2021 Life Sciences Real Estate Outlook
Coupled with broader migration trends happening in the US, new upstart locations become increasingly attractive for investors, developers, tenants, and landlords.
JLL Life Sciences has released its 2021 Life Sciences Real Estate Outlook, which aims to identify the fundamental industry trends driving demand for lab space now and into the future. As core cluster markets generate outsized demand, industry growth and productivity are also being driven by the adoption of new technologies and rapid advancements in innovation.
The life sciences sector is attracting real estate capital from around the globe, with investors targeting legacy markets where industry clusters are strongest and where a density of lab properties already exist. But, strong buyer competition in key clusters, coupled with emerging growth in secondary markets, is driving investment and development activity beyond the traditional geographies.
Read more about the full report here.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
